Aspen Pharmacare Holdings Limited (APN.JO)

22.073,00 +430,00 (+1,99%) Alla chiusura: 04:49PM SAST

Aspen Pharmacare Holdings Limited

Aspen Place
9 Rydall Vale Park Douglas Saunders Drive La Lucia Ridge
Durban
South Africa
27 31 580 8600
https://www.aspenpharma.com

Settore/i: Healthcare
Settore: Drug Manufacturers - Specialty & Generic
Impiegati a tempo pieno: 8.612

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Stephen Bradley Saad BCom, CA(SA)	Group CEO & Executive Director	19,04M	N/D	1964
Mr. Sean M. Capazorio	Group CFO & Executive Director	10,36M	N/D	1967
Ms. Lorraine Hill	Group Chief Operations Officer & Responsible Pharmacist	11,17M	N/D	1964
Mr. Michael Guy Attridge B.Com., CA(SA)	Group Chief Advisor	8,4M	N/D	1961
Mr. Reginald Haman Grad. Dip., MBA, ND, NHD, PGDBA	Group Chief Corporate Services Officer & Executive Director	7,82M	N/D	1975
Ms. Zizipho Mmango	Group Chief Strategic Development Officer	7,82M	N/D	1985
Sibongakonke Nkosi	Investor Relations Manager	N/D	N/D	N/D
Mr. Trevor Julian Ziman	Regional Chief Executive Officer of Asia Pacific	N/D	N/D	1972
Mr. Samer Kassem	Chief Executive Officer of Aspen Global Incorporated	N/D	N/D	1975
Ms. Raeesa Khan	Group Company Secretary	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in ZAc.

Descrizione

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.

Governance aziendale

L'ISS Governance QualityScore di Aspen Pharmacare Holdings Limited al 1 aprile 2024 è 5. I criteri di valutazione fondamentali sono revisione: 7; Consiglio di Amministrazione: 4; diritti degli azionisti: 2; retribuzione: 6.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.